VXA-CoV2-3.1, COMIRNATY®, VXA-CoV2-3.3 — catalyst calendar

1 verified catalyst event(s) referencing VXA-CoV2-3.1, COMIRNATY®, VXA-CoV2-3.3, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-11 (month)
in 4mo
ESTIMATED
READOUT
A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Aut
Phase 2 · SARS-CoV2, COVID-19
VXRT Vaxart, Inc. VXA-CoV2-3.1, COMIRNATY®, VXA-CoV2-3.3 ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.